Advances and challenges in thyroid cancer: The interplay of genetic modulators, targeted therapies, and AI-driven approaches-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advances and challenges in thyroid cancer: The interplay of genetic modulators, targeted therapies, and AI-driven approaches

Published:2023-11 Issue: Volume:332 Page:122110
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Bhattacharya Srinjan,Mahato Rahul Kumar,Singh Satwinder,Bhatti Gurjit Kaur,Mastana Sarabjit Singh,Bhatti Jasvinder Singh

Funder

Indian Council of Medical Research

Science and Engineering Research Board

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference221 articles.

1. Global burden of thyroid cancer and its attributable risk factors in 204 countries and territories from 1990 to 2019;Bao;Thorac. Cancer,2021

2. Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer;Ruel;J. Clin. Endocrinol. Metab.,2015

3. The natural history of benign thyroid nodules;Durante;JAMA,2015

4. Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma;Akaishi;Thyroid,2011

5. Altered epigenetic mechanisms in thyroid cancer subtypes;Zarkesh;Mol. Diagn. Ther.,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New insights into the mechanisms of the extracellular matrix and its therapeutic potential in anaplastic thyroid carcinoma;Scientific Reports;2024-09-09

2. The common pathogenesis of nodular goiter in both sexes: An exploration into gene expression and signaling pathways;Heliyon;2024-07

3. Targeted Therapy in Thyroid Cancer;Indian Journal of Endocrine Surgery and Research;2024-06-17

4. Harnessing Nanotechnology for Idarubicin Delivery in Cancer Therapy: Current Approaches and Future Perspectives;BioNanoScience;2024-04-11

5. Underlying effect of SMAD4 gene polymorphism on risk prediction of papillary thyroid carcinoma in Chinese population;Heliyon;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3